Propanc Biopharma closes $49,200 convertible note financing with 15% interest, net $41,000

Propanc Biopharma, Inc.

Entered securities purchase agreement with 1800 Diagonal Lending LLC for $49,200 convertible note; purchase price $41,000 (includes $8,200 OID).
Note matures March 30, 2025; one-time 15% interest, total payback $56,580 due in five installments starting Nov 30, 2024.
Upon event of default, investor may convert at 65% of lowest trading price in prior 10 days (35% discount).
Proceeds used for general working capital; issuance exempt under Section 4(a)(2) and Rule 506 of Regulation D.
Company has approximately 183.3 million shares of common stock outstanding as of May 22, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.